Antimicrobial Drugs: Mechanisms, Testing, and Resistance

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Drugs Affecting Cell Walls

Antimicrobial drugs that target cell walls interfere with the synthesis or integrity of the peptidoglycan layer, which is essential for bacterial survival.

• Beta-lactams (e.g., penicillins, cephalosporins) inhibit enzymes involved in peptidoglycan cross-linking, leading to cell lysis.

• Vancomycin and bacitracin disrupt different steps in cell wall synthesis.

• Example: Staphylococcus aureus is susceptible to methicillin, a beta-lactam antibiotic.

Drugs Affecting Protein Synthesis

These drugs target bacterial ribosomes, which differ structurally from eukaryotic ribosomes, allowing selective toxicity.

• Aminoglycosides (e.g., streptomycin) cause misreading of mRNA.

• Tetracyclines block tRNA attachment to the ribosome.

• Macrolides (e.g., erythromycin) inhibit translocation of the ribosome along mRNA.

• Example: Tetracycline is used to treat Chlamydia infections.

Drugs Disrupting Cytoplasmic Membranes

Some antimicrobials damage the integrity of the cytoplasmic membrane, causing cell contents to leak out.

• Polymyxins interact with phospholipids, disrupting Gram-negative bacterial membranes.

• Azoles and polyenes (e.g., amphotericin B) target ergosterol in fungal membranes.

• Example: Polymyxin B is used topically for Pseudomonas infections.

Drugs Inhibiting Metabolic Pathways

These drugs block key enzymatic steps in microbial metabolism, often by acting as competitive inhibitors.

• Sulfonamides inhibit folic acid synthesis by mimicking para-aminobenzoic acid (PABA).

• Trimethoprim blocks a later step in folic acid synthesis.

• Example: Sulfamethoxazole is used in combination with trimethoprim for urinary tract infections.

Drugs Inhibiting Nucleic Acid Synthesis

These drugs interfere with DNA replication or RNA transcription in microbes.

• Quinolones (e.g., ciprofloxacin) inhibit DNA gyrase, preventing DNA replication.

• Rifamycins (e.g., rifampin) block RNA polymerase, inhibiting transcription.

• Example: Rifampin is used in the treatment of tuberculosis.

Broad vs. Narrow Spectrum Drugs

Antimicrobial drugs vary in the range of organisms they affect.

• Broad-spectrum drugs are effective against a wide variety of microbial species (e.g., tetracycline).

• Narrow-spectrum drugs target specific groups or species (e.g., penicillin G is mainly effective against Gram-positive bacteria).

• Comparison Table:

Type	Advantages	Disadvantages
Broad-spectrum	Treats mixed infections; useful when pathogen is unknown	May disrupt normal microbiota; higher risk of superinfection
Narrow-spectrum	Less impact on normal flora; lower risk of resistance	Requires identification of pathogen

Diffusion Susceptibility Test (Kirby-Bauer Test)

This test evaluates the effectiveness of antibiotics against specific bacteria.

• Paper disks impregnated with antibiotics are placed on an agar plate inoculated with the test organism.

• Zones of inhibition (clear areas) indicate susceptibility.

• Interpretation is based on the diameter of the zone compared to standard charts.

• Example: A large zone of inhibition around a penicillin disk indicates sensitivity.

Minimum Inhibitory Concentration (MIC) Test

The MIC test determines the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism.

• Serial dilutions of the drug are prepared in broth and inoculated with the test organism.

• The MIC is the lowest concentration with no visible growth.

• Equation:

$\text{MIC} = \min \{ C : \text{no visible growth at concentration } C \}$

• Example: An MIC of 2 µg/mL for vancomycin against Enterococcus species.

Minimum Bactericidal Concentration (MBC) Test

The MBC test identifies the lowest concentration of an antimicrobial that kills 99.9% of the original inoculum.

• Samples from MIC tubes with no growth are subcultured onto drug-free media.

• The MBC is the lowest concentration with no colony growth.

• Example: MBC is higher than MIC if the drug is bacteriostatic rather than bactericidal.

Routes of Administration for Antimicrobial Drugs

Drugs can be administered by various routes, each with benefits and drawbacks.

• Oral: Convenient, but absorption may be variable.

• Intramuscular (IM): Allows higher concentrations, but may be painful.

• Intravenous (IV): Rapid and reliable delivery, but requires medical supervision.

• Topical: Used for skin infections; minimal systemic effects.

• Table:

Route	Advantages	Drawbacks
Oral	Easy, self-administered	Variable absorption, patient compliance
IM	Higher, sustained levels	Pain, risk of infection
IV	Immediate effect	Requires IV access, risk of complications
Topical	Localized effect	Limited to surface infections

Safety and Side Effects of Antimicrobial Agents

While effective, antimicrobial drugs can cause adverse effects.

• Allergic reactions: Ranging from mild rashes to anaphylaxis.

• Toxicity: Some drugs (e.g., aminoglycosides) can damage kidneys or hearing.

• Disruption of normal microbiota: May lead to superinfections (e.g., Clostridioides difficile colitis).

Bacterial Resistance to Antibiotics

Bacteria can acquire resistance through genetic mutations or horizontal gene transfer.

• Mechanisms:

  • Enzymatic drug inactivation (e.g., beta-lactamases)

  • Altered drug targets (e.g., modified ribosomal proteins)

  • Efflux pumps expel drugs from the cell

  • Reduced permeability to drugs

• Example: MRSA (methicillin-resistant Staphylococcus aureus) produces altered penicillin-binding proteins.

Limiting Antibiotic Resistance: Patient Actions

Patients play a crucial role in reducing the spread of resistance.

• Take antibiotics exactly as prescribed; complete the full course.

• Do not demand antibiotics for viral infections.

• Avoid sharing or saving leftover antibiotics.

• Practice good hygiene to prevent infections.

Antibiotic Resistance in Healthcare: Causes, Impact, and Solutions

Antibiotic resistance is a growing problem with significant health and economic consequences.

• Causes: Overuse and misuse of antibiotics, poor infection control, agricultural use of antibiotics.

• Impact: Increased morbidity, mortality, and healthcare costs; limited treatment options.

• Solutions: Stewardship programs, surveillance, infection prevention, development of new drugs, public education.

• Example: The rise of carbapenem-resistant Enterobacteriaceae (CRE) in hospitals.

Additional info: Where the original study guide was brief, academic context and examples have been added to ensure completeness and clarity for exam preparation.